Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...
The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...
The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...
Joe Chang gives a presentation on using proton therapy for lung cancer. He talks about the advantages over photons, the improvements of IMPT compared to PSPT...